Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Steris to add contract sterilization services with $142 mil. Isomedix acquisition.

This article was originally published in The Gray Sheet

Executive Summary

STERIS WOULD ADD CONTRACT STERILIZATION SERVICES WITH $142 MIL. ISOMEDIX BUY announced Aug. 12. The firms have entered a definitive merger agreement that would result in Steris' adding the complementary business of contract sterilization to its line of infection prevention, contamination prevention, and surgical support systems and services. Isomedix provides gamma radiation and ethylene oxide contract sterilization services to manufacturers of pre-packaged medical devices and consumer products.

You may also be interested in...



Steris' Isotron Acquisition Adds European Contract Sterilization Services

The purchase of contract sterilization and related services firm Isotron gives Steris a foothold in the European market on which to further expand throughout the continent. Announced July 20, the cash deal is valued at $110 mil.

The Generics Bulletin Top 50, Part One: Industry Top 10 Reshaped By Leaders’ Transformations

A new entrant into the top five global generics and biosimilars companies shows how transformations for some of the leading off-patent players are reshaping the industry landscape, with more major changes in the pipeline. We examine the 10 leaders of the pack in the first instalment of this year’s Generics Bulletin Top 50.

Latest News
See All
UsernamePublicRestriction

Register

MT008618

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel